Modification of dendritic cells with interferon-γ -inducible protein-10 gene to enhance vaccine potency

Journal of Gene Medicine

Volumn 11, Issue 10, 2009, Pages 889-898

  Kang, Tae Heung ^a   Bae, Hyun Cheol ^a   Kim, Seok Ho ^a   Seo, Su Hong ^b   Son, Sang Wook ^b   Choi, Eun Young ^c   Seong, Seung Yong ^c   Kim, Tae Woo ^a  

^a Korea University College of Medicine   (South Korea)

^b Korea University College of Medicine   (South Korea)

^c Seoul National University College of Medicine   (South Korea)

Author keywords

Cancer vaccine; Chemokine; Dendritic cell; Immunotherapy; IP 10

Indexed keywords

B7 ANTIGEN; CD40 ANTIGEN; CD8 ANTIGEN; DENDRITIC CELL VACCINE; DNA; GAMMA INTERFERON INDUCIBLE PROTEIN 10; TUMOR ANTIGEN;

ANIMAL CELL; ANTIGEN SPECIFICITY; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER IMMUNOTHERAPY; CD8+ T LYMPHOCYTE; CELL CULTURE; CELL MATURATION; CELLULAR IMMUNITY; CHEMOTAXIS; CONTROLLED STUDY; CYTOLOGY; DENDRITIC CELL; DNA MODIFICATION; DOWN REGULATION; DRUG POTENCY; DRUG POTENTIATION; FEMALE; IN VITRO STUDY; IN VIVO STUDY; LUNG CANCER; MOUSE; NEGATIVE FEEDBACK; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RETROVIRUS; T LYMPHOCYTE; UPREGULATION;

ANIMALS; ANTIGENS, CD40; ANTIGENS, CD80; CANCER VACCINES; CD8-POSITIVE T-LYMPHOCYTES; CELL CULTURE TECHNIQUES; CELL LINE; CHEMOKINE CXCL10; CHEMOTACTIC FACTORS; DENDRITIC CELLS; FEMALE; GENETIC VECTORS; HUMANS; LUNG NEOPLASMS; LYMPHOCYTE ACTIVATION; MICE; RETROVIRIDAE; TRANSDUCTION, GENETIC; UP-REGULATION;

MUS;

EID: 72449175976     PISSN: 1099498X     EISSN: 15212254     Source Type: Journal    
DOI: 10.1002/jgm.1371     Document Type: Article

References (34)

1. Steinman RM. The dendritic cell system and its role in immunogenicity. Ann Review Immunol 1991; 9: 271-296.
2. Reddy ST, Swartz MA, Hubbell JA. Targeting dendritic cells with biomaterials: developing the next generation of vaccines. Trends Immunol 2006; 27: 573-579.
3. Klebanoff CA, Gattinoni L, Restifo NP. CD8+ T-cell memory in tumor immunology and immunotherapy. Immunol Rev 2006; 211: 214-224. (Pubitemid 43882974)
4. Fukada K, Sobao Y, Tomiyama H, Oka S, Takiguchi M. Functional expression of the chemokine receptor CCR5 on virus epitope-specific memory and effector CD8+ T cells. J Immunol 2002; 168: 2225-2232. (Pubitemid 34171822)
5. Nishimura M, Hisanori U, Nakayama T, et al. Dual functions of fractalkine/CX3C ligand 1 in trafficking of perforin+/granzyme B+ cytotoxic effector lymphocytes that are defined by CX3CR1 expression. J Immunol 2002; 168: 6173-6180. (Pubitemid 34620036)
6. Moser B, Loetscher P. Lymphocyte traffic control by chemokines. Nature immunology 2001; 2: 123-128.
7. Dufour JH, Dziejman M, Liu MT, Leung JH, Lane TE, Luster AD. IFN-gamma-inducible protein 10 (IP-10; CXCL10)-deficientmice reveal a role for IP-10 in effector T cell generation and trafficking. J Immunol 2002; 168: 3195-3204. (Pubitemid 34256349)
8. Christensen JE, de Lemos C, Moos T, Christensen JP, Thomsen AR. CXCL10 is the key ligand for CXCR3 on CD8+ effector T cells involved in immune surveillance of the lymphocytic choriomeningitis virus-infected central nervous system. J Immunol 2006; 176: 4235-4243. (Pubitemid 44264402)
9. Krathwohl MD, Anderson JL. Chemokine CXCL10 (IP-10) is sufficient to trigger an immune response to injected antigens in a mouse model. Vaccine 2006; 24: 2987-2993.
10. Qian C, An H, Yu Y, Liu S, Cao X. TLR agonists induce regulatory dendritic cells to recruit Th1 cells via preferential IP-10 secretion and inhibit Th1 proliferation. Blood 2007; 109: 3308-3315. (Pubitemid 46572518)
11. Kawai T, Takeuchi O, Fujita T, et al. Lipopolysaccharide stimulates the MyD88-independent pathway and results in activation of IFN-regulatory factor 3 and the expression of a subset of lipopolysaccharide-inducible genes. J Immunol 2001; 167: 5887-5894. (Pubitemid 33062783)
12. Yang J, Richmond A. The angiostatic activity of interferon-inducible protein-10/CXCL10 in human melanoma depends on binding to CXCR3 but not to glycosaminoglycan. Mol Ther 2004; 9: 846-855. (Pubitemid 38878130)
13. Lin KY, Guarnieri FG, Staveley-O'Carroll KF, et al. Treatment of established tumors with a novel vaccine that enhances major histocompatibility class II presentation of tumor antigen. Cancer Res 1996; 56: 21-26.
14. Shen Z. Cloned dendritic cells can present exogenous antigens on both MHC class I and class II molecules. J Immunol 1997; 158: 2723-2730. (Pubitemid 127470530)
15. Kim TW, Hung CF, Boyd D, et al. Enhancing DNA vaccine potency by combining a strategy to prolong dendritic cell life with intracellular targeting strategies. J Immunol 2003; 171: 2970-2976. (Pubitemid 37093519)
16. Kang TH, Lee JH, Bae CH, et al. Enhancement of dendritic cell-based vaccine potency by targeting antigen to endosomal/lysosomal compartments. Immunol Lett 2006; 106: 126-134.
17. Kang TH, Lee JH, Noh KH, et al. Enhancing dendritic cell vaccine potency by combining a BAK/BAX siRNA-mediated antiapoptotic strategy to prolong dendritic cell life with an intracellular strategy to target antigen to lysosomal compartments. Int J Cancer 2007; 120: 1696-1703. (Pubitemid 46399356)
18. Kang TH, Lee JH, Noh KH, Song CK, et al. Epigallocatechin-3-gallate enhances CD8+ T cell-mediated antitumor immunity induced by DNA vaccination. Cancer Research 2007; 67: 802-811. (Pubitemid 46192221)
19. Kim TW, Hung CF, Juang J, He L, Hardwick JM, Wu TC. Enhancement of suicidal DNA vaccine potency by delaying suicidal DNA-induced cell death. Gene Ther 2004; 11: 336-342. (Pubitemid 38220086)
20. Idzko M, Panther E, Corinti S, et al. Sphingosine 1-phosphate induces chemotaxis of immature andmodulates cytokine-release in mature human dendritic cells for emergence of Th2 immune responses. FASEB J 2002; 16: 625-627.
21. Tourkova IL, Yurkovetsky ZR, Shurin MR, Shurin GV. Mechanisms of dendritic cell-induced T cell proliferation in the primary MLR assay. Immunol Lett 2001; 78: 75-82.
22. Chen CH, Wang TL, Hung CF, Pardoll DM, Wu TC. Boosting with recombinant vaccinia increases HPV-16 E7-specific T cell precursor frequencies of HPV-16 E7-expressing DNA vaccines. Vaccine 2000; 18: 2015-2022.
23. Lin CH, Hung CF, Juang J, et al. Boosting with recombinant vaccinia increases HPV-16 E7-specific T cell precursor frequencies and antitumor effects of HPV-16 E7-expressing Sindbis virus replicon particles. Mol Ther 2003; 8: 559-566. (Pubitemid 37321684)
24. Kim TW, Lee JH, He L, et al. Modification of professional antigen-presenting cells with small interfering RNA in vivo to enhance cancer vaccine potency. Cancer Res 2005; 65: 309-316. (Pubitemid 40070823)
25. Luster AD. Chemokines - chemotactic cytokines that mediate inflammation. New Eng J Med 1998; 338: 436-445.
26. Meier CA, Chicheportiche R, Dreyer M, Dayer JM. IP-10, but not RANTES, is upregulated by leptin in monocytic cells. Cytokine 2003; 21: 43-47. (Pubitemid 36369376)
27. Kaplan G, Luster AD, Hancock G, Cohn ZA. The expression of a gamma interferon-induced protein (IP-10) in delayed immune responses in human skin. J Exp Med 1987; 166: 1098-1108. (Pubitemid 18024249)
28. Penna G, Vulcano M, Sozzani S, Adorini L. Differential migration behavior and chemokine production by myeloid and plasmacytoid dendritic cells. Hum Immunol 2002; 63: 1164-1171. (Pubitemid 36025991)
29. Gangur V, Simons FE, Hayglass KT. Human IP-10 selectively promotes dominance of polyclonally activated and environmental antigen-driven IFN-gamma over IL-4 responses. FASEB J 1998; 12: 705-713. (Pubitemid 28247149)
30. Pertl U, Luster AD, Varki NM, et al. IFN-gamma-inducible protein-10 is essential for the generation of a protective tumor-specific CD8 T cell response induced by single-chain IL-12 gene therapy. J Immunol 2001; 166: 6944-6951. (Pubitemid 32467242)
31. Sgadari C, Angiolillo AL, Cherney BW, et al. Interferon-inducible protein-10 identified as a mediator of tumor necrosis in vivo. Proc Natl Acad Sci USA 1996; 93: 13791-13796. (Pubitemid 26424199)
32. Li X, Mukai T, Young D, Frankel S, Law P, Wong-Staal F. Transduction of CD34+cells by a vesicular stomach virus protein G (VSV-G) pseudotyped HIV-1 vector. Stable gene expression in progeny cells, including dendritic cells. J Hum Virol 1998; 1: 346-352. (Pubitemid 128543455)
33. Cronin J, Zhang XY, Reiser J, et al. Altering the tropism of lentiviral vectors through pseudotyping. Curr Gene Ther 2005; 5: 387-398. (Pubitemid 41052430)
34. Hsieh CJ, Kim TW, Hung CF, et al. Enhancement of vaccinia vaccine potency by linkage of tumor antigen gene to gene encoding calreticulin. Vaccine 2004; 22: 3993-4001. (Pubitemid 39208763)